UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Addition of clarithromycin to lenalidomide/low-dose dexamethasone was effective in a case of relapsed myeloma after long-term use of lenalidomide

Annals of hematology, 2013-12, Vol.92 (12), p.1711-1712

2013

Volltextzugriff (PDF)

Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan

Journal of Clinical and Experimental Hematopathology, 2024, Vol.64(3), pp.216-222

2024

Volltextzugriff (PDF)

Aleukemic T-lymphoblastic leukemia/lymphoma with massive cerebrospinal fluid infiltration

Journal of hematopathology, 2022-06, Vol.15 (2), p.105-109

2022

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type

Leukemia & lymphoma, 2010-08, Vol.51 (8), p.1509-1512

2010

Volltextzugriff (PDF)

Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde‐derived advanced glycation end‐product formation

Journal of leukocyte biology, 2014-12, Vol.96 (6), p.1077-1085

2014

Volltextzugriff (PDF)

Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma

International journal of hematology, 2020-03, Vol.111 (3), p.409-416

2020

Volltextzugriff (PDF)

Anaplastic multiple myeloma: possible limitations of conventional chemotherapy for long-term remission

Journal of Clinical and Experimental Hematopathology, 2018, Vol.58(1), pp.39-42

2018

Volltextzugriff (PDF)

Anaplastic multiple myeloma with MYC rearrangement

Leukemia research reports, 2022-01, Vol.17, p.100288, Article 100288

2022

Volltextzugriff (PDF)

Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan

International journal of hematology, 2017-04, Vol.105 (4), p.470-477

2017

Volltextzugriff (PDF)

Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS)

Annals of hematology, 2013-01, Vol.92 (1), p.1-9

2013

Volltextzugriff (PDF)

Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis

Experimental hematology & oncology, 2013-08, Vol.2 (1), p.19-19, Article 19

2013

Volltextzugriff (PDF)

Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study

Blood advances, 2023-09, Vol.7 (17), p.4903-4912

2023

Volltextzugriff (PDF)

Diffuse large B-cell lymphoma of the skull vault

International journal of hematology, 2024-03, Vol.119 (3), p.215-216

2024

Volltextzugriff (PDF)

Does double-hit follicular lymphoma with translocations of MYC and BCL2 change the definition of transformation?

Leukemia & lymphoma, 2018-03, Vol.59 (3), p.758-762

2018

Volltextzugriff (PDF)

Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data

International journal of hematology, 2020-12, Vol.112 (6), p.807-816

2020

Volltextzugriff (PDF)

Effects of in vivo deletion of GATA2 in bone marrow stromal cells

Experimental hematology, 2017-12, Vol.56, p.31-45.e2

2017

Volltextzugriff (PDF)

Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma

Cancer science, 2016-12, Vol.107 (12), p.1785-1790

2016

Volltextzugriff (PDF)

Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma

International journal of hematology, 2022-10, Vol.116 (4), p.563-569

2022

Volltextzugriff (PDF)

Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial

International journal of hematology, 2023-02, Vol.117 (2), p.251-259

2023

Volltextzugriff (PDF)

Elucidation of the role of LMO2 in human erythroid cells

Experimental hematology, 2013-12, Vol.41 (12), p.1062-1076.e1

2013

Volltextzugriff (PDF)

Epstein-Barr virus-positive diffuse large B-cell lymphoma after sustained remission of T-cell prolymphocytic leukemia with alemtuzumab

Leukemia & lymphoma, 2020-05, Vol.61 (6), p.1504-1507

2020

Volltextzugriff (PDF)

Extranasal extranodal NK/T-cell lymphoma associated with systemic lupus erythematosus

International journal of hematology, 2020-10, Vol.112 (4), p.592-596

2020

Volltextzugriff (PDF)

Fatal Visceral Varicella-Zoster Developing Early after Autologous Hematopoietic Stem Cell Transplantation for Refractory Diffuse Large B-Cell Lymphoma

Journal of Clinical and Experimental Hematopathology, 2014, Vol.54(3), pp.237-241

2014

Volltextzugriff (PDF)

Favorable Outcome of Unrelated Cord Blood Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Biology of blood and marrow transplantation, 2011-07, Vol.17 (7), p.1093-1097

2011

Volltextzugriff (PDF)

Final analysis of a phase II study of ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma

Journal of Clinical and Experimental Hematopathology, 2019, Vol.59(2), pp.98-100

2019

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Aktive Filter

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(77)

Sprache

Englisch
(77)

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Life Sciences & Biomedicine
(70)
Humans
(55)
Oncology
(45)
Medicine
(36)
Medicine & Public Health
(34)
Female
(30)
Middle Aged
(24)
Male
(22)
Adult
(18)
Lymphoma
(16)
Original Article
(15)
Letter To The Editor
(13)
Treatment Outcome
(12)
Aged
(11)
Patients
(10)
Young Adult
(10)
Adolescent
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Addition of clarithromycin to lenalidomide/low-dose dexamethasone was effective in a case of relapsed myeloma after long-term use of lenalidomide

Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan

Aleukemic T-lymphoblastic leukemia/lymphoma with massive cerebrospinal fluid infiltration

Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type

Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde‐derived advanced glycation end‐product formation

Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma

Anaplastic multiple myeloma: possible limitations of conventional chemotherapy for long-term remission

Anaplastic multiple myeloma with MYC rearrangement

Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan

Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS)

Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis

Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study

Diffuse large B-cell lymphoma of the skull vault

Does double-hit follicular lymphoma with translocations of MYC and BCL2 change the definition of transformation?

Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data

Effects of in vivo deletion of GATA2 in bone marrow stromal cells

Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma

Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma

Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial

Elucidation of the role of LMO2 in human erythroid cells

Epstein-Barr virus-positive diffuse large B-cell lymphoma after sustained remission of T-cell prolymphocytic leukemia with alemtuzumab

Extranasal extranodal NK/T-cell lymphoma associated with systemic lupus erythematosus

Fatal Visceral Varicella-Zoster Developing Early after Autologous Hematopoietic Stem Cell Transplantation for Refractory Diffuse Large B-Cell Lymphoma

Favorable Outcome of Unrelated Cord Blood Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Final analysis of a phase II study of ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma

Aktive Filter

Suchergebnisse filtern